Article Information
PubMed
Published By
Online ISSN
History
- Received January 25, 2018
- Revision received May 18, 2018
- Accepted May 22, 2018
- Published online June 1, 2018.
Copyright & Usage
© 2018 Xia et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).
Author Information
- Yi Xia1,
- Yasheen Zhou1,
- David S Carter1,
- Matthew B McNeil2,
- Wai Choi1,
- Jason Halladay1,
- Pamela W Berry1,
- Weimin Mao1,
- Vincent Hernandez1,
- Theresa O'Malley2,
- Aaron Korkegian2,
- Bjorn Sunde2,
- Lindsay Flint2,
- Lisa K Woolhiser3,
- Michael S Scherman3,
- Veronica Gruppo3,
- Courtney Hastings3,
- Gregory T Robertson3,
- Thomas R Ioerger4,
- Jim Sacchettini4,
- Peter J Tonge5,
- Anne J Lenaerts3,
- Tanya Parish2⇑ and
- MRK Alley1
- 1Anacor Pharmaceuticals, Palo Alto, CA, USA
- 2TB Discovery Research, Infectious Disease Research Institute, Seattle, WA, USA
- 3Mycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA
- 4Texas A&M University, College Station, TX, USA
- 5Institute of Chemical Biology and Drug Discovery, Departments of Chemistry and Radiology, Stony Brook University, Stony Brook, NY, USA
- Correspondence: tanya.parish{at}idri.org
Funding
Bill & Melinda Gates Foundation
NIH
GM102864PJ Tonge
Direct inhibition of Mycobacterium tuberculosis InhA
In this Issue
Advertisement